Marilyn Icsman

Jul 4, 2024 | mondaq.com | Andrew London |Ross Margulies |Beth Neitzel |Marilyn Icsman

FH Foley Hoag LLP More Foley Hoag provides innovative, strategic legal services to public, private and government clients. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse experiences of our lawyers contribute to the exceptional senior-level service we deliver to clients. On June 28, 2024, in Loper Bright Enterprises v.

Jul 3, 2024 | jdsupra.com | Thomas Barker |Regina DeSantis |Marilyn Icsman

Key Takeaways: On June 28, 2024, in Loper Bright Enterprises v. Raimondo and Relentless, Inc. v. Department of Commerce (“Loper Bright”), the Supreme Court struck down the doctrine of Chevron deference, ending four decades of judicial deference to agency interpretations of ambiguous statutes. Deference to federal agencies will now be permitted only when Congress has expressly delegated such authority—and even then only as applied to factual determinations.

Mar 12, 2024 | mondaq.com | Marilyn Icsman

Attorneys general across the country have joined in litigation related to mifepristone, a drug used for medication abortions. A case currently before the Supreme Court, FDA v. Alliance for Hippocratic Medicine, could affect access to the drug by invalidating FDA guidelines from 2016 and 2021 that loosened restrictions on prescribing and administering mifepristone. A key issue in the case relates to telehealth services.

Mar 4, 2024 | lexblog.com | Marilyn Icsman

Attorneys general across the country have joined in litigation related to mifepristone, a drug used for medication abortions. A case currently before the Supreme Court, FDA v. Alliance for Hippocratic Medicine, could affect access to the drug by invalidating FDA guidelines from 2016 and 2021 that loosened restrictions on prescribing and administering mifepristone. A key issue in the case relates to telehealth services.